Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Abbott Laboratories (NY:ABT)

105.51 -0.10 (-0.09%)
Streaming Delayed Price Updated: 1:22 PM EDT, Jul 31, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Abbott Laboratories

< Previous 1 2
...
19 20 21 22 23 24 25 26 27
...
57 58 Next >
Global Sports Nutrition Market Projected to Reach $78 Billion as Muscle Repair & Growth Becoming Vitally Important
EQNX::TICKER_START (OTCPK:MUSLF),(CSE:MUSL),(NYSE:ABT),(NASDAQ:CELH),(NASDAQ:MNST),(NYSE:BRBR) EQNX::TICKER_END 
Via FinancialNewsMedia
News headline image
Jim Cramer Calls This Healthcare Stock A 'Worthy Spec,' Recommends Avoiding Canada Goose ↗
Cramer recommends staying away from Canada Goose, even though it reported better-than-expected Q4 earnings. 
Via Benzinga
News headline image
3 S&P 500 Stocks That Have Proven Themselves Recession-Proof ↗
Corrections are a part of investing and investors would be smart to have these three S&P 500 stocks to buy when the inevitable happens. 
Via InvestorPlace
Topics Stocks
News headline image
These Dividend Stocks Are an Investor's Best Friend ↗
These two healthcare stocks are well-known for their top-tier dividend programs. 
Via The Motley Fool
News headline image
Looking At Abbott Laboratories's Recent Unusual Options Activity ↗
 
Via Benzinga
News headline image
How Is The Market Feeling About Abbott Laboratories? ↗
 
Via Benzinga
News headline image
Global Sports Nutrition Market Projected to Reach $78 Billion as Muscle Repair & Growth Becoming Vitally Important
From FN Media Group LLC
Via GlobeNewswire
News headline image
Best Foundational Stocks ↗
Building the foundation of investors portfolio with the best US foundational stocks by sector. 
Via Talk Markets
News headline image
What the Options Market Tells Us About Abbott Laboratories ↗
 
Via Benzinga
News headline image
Behind the Scenes of Abbott Laboratories's Latest Options Trends ↗
 
Via Benzinga
News headline image
Catalyst's New CEO Has Big Ideas For The Small Biotech ↗
Richard Daly is Catalyst Pharmaceuticals' second CEO, taking over for Patrick McEnany, who retired last year. 
Via Investor's Business Daily
News headline image
Amazon, Abbott Laboratories And 2 Other Stocks Insiders Are Selling ↗
 
Via Benzinga
News headline image
Got $1,000? 3 Dividend Stocks to Buy and Hold Forever ↗
Check out these healthcare stocks for some healthy payouts. 
Via The Motley Fool
News headline image
Stock Market Crash Alert: 3 Must-Buy Healthcare Stocks When Prices Plunge ↗
Investors should look for opportunities to buy these leading healthcare companies, each of which posted strong Q1 results. 
Via InvestorPlace
Intelligent Bio Solutions Screening Technologies Poised to Disrupt The Healthcare Sector: INBS, LH, ABT, DGX
Via AB Newswire
News headline image
Boston Scientific Bucks the Medtech Slow Down and Raises Outlook
Medical device maker Boston Scientific Co. defies Medtech slowdown and delivers a solid Q1 2024 earnings report, and raises 2024 outlook. 
Via MarketBeat
News headline image
7 Defensive Stocks Built to Withstand the Market’s Worst Storms ↗
With the market operating under a worrisome backdrop, investors may want to target certain defensive stocks to buy. 
Via InvestorPlace
News headline image
2 Beaten-Down Dividend Stocks to Buy and Hold Forever ↗
These companies aren't in danger of becoming has-beens. 
Via The Motley Fool
News headline image
Better Dividend Stock: AbbVie or Johnson & Johnson? ↗
One thing is for sure: Dividend seekers can't go wrong with either. 
Via The Motley Fool
News headline image
3 Dividend Stocks to Buy and Hold for the Next Decade ↗
You'll get dividends and more with these great stocks. 
Via The Motley Fool
News headline image
Intelligent Bio Solutions’ Fingerprint Drug Screening Technology Poised For Massive Growth ↗
Intelligent Bio Solutions (Nasdaq: INBS) is a medical technology company developing and commercializing innovative, intelligent, rapid, noninvasive testing solutions. 
Via Talk Markets
News headline image
Dividend Growth Stars: 7 Stocks With 10-Year Double-Digit Rate Hikes ↗
It's not just enough for a company to pay a dividend, investors should look for dividend growth stocks that can continue to pay. 
Via InvestorPlace
News headline image
3 Dividend Kings Down 11% You’ll Regret Not Buying on the Dip ↗
These dividend stocks have proved time and again why they're the cream of the crop and will rise to the top once more. 
Via InvestorPlace
News headline image
Stock Market Sells Off; Taiwan Semi, ASML, Netflix, Tesla In Focus: Weekly Review ↗
The Nasdaq and S&P 500 tumbled below their 50-day lines. 
Via Investor's Business Daily
Topics Stocks
News headline image
Stocks Fall As Geopolitics, Economic Worries Spook Investors, Chipmakers Sell Off, Bitcoin Tumbles To $60,000: What's Driving Markets Wednesday? ↗
A sentiment of risk aversion looms over the markets during Wednesday’s trading session, triggering midday losses across the board in stocks and cryptocurrencies and prompting a flight towards bonds, as... 
Via Benzinga
Topics Bonds
News headline image
Abbott Laboratories (ABT) Q1 2024 Earnings Call Transcript ↗
ABT earnings call for the period ending March 31, 2024. 
Via The Motley Fool
Topics Earnings
News headline image
ABT Stock Earnings: Abbott Laboratories Beats EPS, Beats Revenue for Q1 2024 ↗
ABT stock results show that Abbott Laboratories beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
News headline image
Abbott Laboratories Outlook is Healthy: Buy the Dip
Abbott Laboratories had a steady quarter, producing growth, better-than-expected earnings, and raising the guidance. Analysts see the stock moving higher. 
Via MarketBeat
News headline image
Abbott Beats Q1 Expectations With $10 Billion In Sales, $0.98 EPS ↗
Abbott has reported a strong start to the year with sales reaching $10.0 billion in Q1, driven by a 10.8 percent increase in organic sales growth. 
Via Talk Markets
News headline image
Dow Surges 200 Points; Abbott Laboratories Posts Upbeat Earnings ↗
U.S. stocks traded higher this morning, with the Dow Jones index gaining around 200 points on Wednesday. Following the market opening Wednesday, the Dow traded up 0.55% to 38,006.47 while the NASDAQ... 
Via Benzinga
Topics Stocks
< Previous 1 2
...
19 20 21 22 23 24 25 26 27
...
57 58 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.